Lectin galactoside-binding soluble 3 binding protein (LGALS3BP) is a tumor-associated immunomodulatory ligand for CD33-related siglecs

Journal of Biological Chemistry

Volumn 289, Issue 48, 2014, Pages 33481-33491

  Läubli, Heinz ^a,b   Alisson Silva, Frederico ^a   Stanczak, Michal A ^a   Siddiqui, Shoib S ^a   Deng, Liwen ^a   Verhagen, Andrea ^a   Varki, Nissi ^a   Varki, Ajit ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; CARBOXYLIC ACIDS; CELL ADHESION; DISEASES; ENZYME INHIBITION; LIGANDS; MOLECULES; TUMORS;

BINDING PROTEINS; CANCER PROGRESSION; EXTRACELLULAR MATRICES; IMMUNE FUNCTION; IMMUNE RESPONSE; IMMUNOMODULATORY; PROSTATE CANCERS; SECRETED MOLECULES;

PROTEINS;

BINDING PROTEIN; CD33 ANTIGEN; CELL EXTRACT; LECTIN GALACTOSIDE BINDING SOLUBLE 3 BINDING PROTEIN; LIGAND; PROTEIN SIGLEC 10; PROTEIN SIGLEC 5; PROTEIN SIGLEC 9; SIALIC ACID; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; UNCLASSIFIED DRUG; CARRIER PROTEIN; CD33 PROTEIN, HUMAN; CD33 PROTEIN, MOUSE; GLYCOPROTEIN; IMMUNOLOGIC FACTOR; LGALS3BP PROTEIN, HUMAN; TUMOR ANTIGEN; TUMOR MARKER; TUMOR PROTEIN;

AFFINITY CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; CANCER CELL; CANCER GROWTH; COLORECTAL CANCER; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOMODULATION; LEUKOCYTE ACTIVATION; NONHUMAN; PROSTATE CANCER; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE HOMOLOGY; TUMOR IMMUNOLOGY; UPREGULATION; ANIMAL; BIOSYNTHESIS; COLORECTAL TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; MALE; METABOLISM; MOUSE; PATHOLOGY; PROSTATE TUMOR; TUMOR ESCAPE;

ANIMALS; ANTIGENS, NEOPLASM; BIOMARKERS, TUMOR; CARRIER PROTEINS; COLORECTAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLYCOPROTEINS; HEK293 CELLS; HUMANS; IMMUNOLOGIC FACTORS; MALE; MICE; NEOPLASM PROTEINS; PROSTATIC NEOPLASMS; SIALIC ACID BINDING IG-LIKE LECTIN 3; TUMOR ESCAPE; UP-REGULATION;

EID: 84912101312     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.593129     Document Type: Article

References (66)

1. Schreiber, R. D., Old, L. J., and Smyth, M. J. (2011) Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 331, 1565-1570
2. Trinchieri, G., and Sher, A. (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat. Rev. Immunol. 7, 179-190
3. Latz, E., Xiao, T. S., and Stutz, A. (2013) Activation and regulation of the inflammasomes. Nat. Rev. Immunol. 13, 397-411
4. Parham, P. (2008) The genetic and evolutionary balances in human NK cell receptor diversity. Semin. Immunol. 20, 311-316
5. Varki, A. (2011) Because there are PAMPs and DAMPs, there must be SAMPs? Glycan "self-associated molecular patterns" dampen innate immunity, but pathogens can mimic them. Glycobiology 21, 1121-1124
6. Crocker, P. R., Paulson, J. C., and Varki, A. (2007) Siglecs and their roles in the immune system. Nat. Rev. Immunol. 7, 255-266
7. von Gunten, S., and Bochner, B. S. (2008) Basic and clinical immunology of Siglecs. Ann. N.Y. Acad. Sci. 1143, 61-82
8. Varki, A., and Crocker, P. R. (2009) in Essentials of Glycobiology (Varki, A., Cummings, R. D., Esko, J. D., Freeze, H. H., Stanley, P., Bertozzi, C. R., Hart, G. W., and Etzler, M. E., eds.) pp. 459-474, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
9. Pillai, S., Mattoo, H., and Cariappa, A. (2011) B cells and autoimmunity. Curr. Opin. Immunol. 23, 721-731
10. Crocker, P. R., McMillan, S. J., and Richards, H. E. (2012) CD33-related siglecs as potential modulators of inflammatory responses. Ann. N.Y. Acad. Sci. 1253, 102-111
11. Varki, A., and Gagneux, P. (2012) Multifarious roles of sialic acids in immunity. Ann. N.Y. Acad. Sci. 1253, 16-36
12. Padler-Karavani, V., Hurtado-Ziola, N., Chang, Y. C., Sonnenburg, J. L., Ronaghy, A., Yu, H., Verhagen, A., Nizet, V., Chen, X., Varki, N., Varki, A., and Angata, T. (2014) Rapid evolution of binding specificities and expression patterns of inhibitory CD33-related Siglecs in primates. FASEB J. 28, 1280-1293
13. Ali, S. R., Fong, J. J., Carlin, A. F., Busch, T. D., Linden, R., Angata, T., Areschoug, T., Parast, M., Varki, N., Murray, J., Nizet, V., and Varki, A. (2014) Siglec-5 and Siglec-14 are polymorphic paired receptors that modulate neutrophil and amnion signaling responses to group B Streptococcus. J. Exp. Med. 211, 1231-1242
14. Carlin, A. F., Uchiyama, S., Chang, Y. C., Lewis, A. L., Nizet, V., and Varki, A. (2009) Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood 113, 3333-3336
15. Carlin, A. F., Chang, Y. C., Areschoug, T., Lindahl, G., Hurtado-Ziola, N., King, C. C., Varki, A., and Nizet, V. (2009) Group B Streptococcus suppression of phagocyte functions by protein-mediated engagement of human Siglec-5. J. Exp. Med. 206, 1691-1699
16. Jandus, C., Boligan, K. F., Chijioke, O., Liu, H., Dahlhaus, M., Démoulins, T., Schneider, C., Wehrli, M., Hunger, R. E., Baerlocher, G. M., Simon, H. U., Romero, P., Münz, C., and von Gunten, S. (2014) Interactions between Siglec-7/9 receptors and ligands influence NK cell-dependent tumor immunosurveillance. J. Clin. Invest. 124, 1810-1820
17. Läubli, H., Pearce, O. M., Schwarz, F., Siddiqui, S. S., Deng, L., Stanczak, M. A., Deng, L., Verhagen, A., Secrest, P., Lusk, C., Schwartz, A. G., Varki, N. M., Bui, J. D., and Varki, A. (2014) Engagement of myelomonocytic Siglecs by tumor-associated ligands modulates the innate immune response to cancer. Proc. Natl. Acad. Sci. U.S.A. 111, 14211-14216
18. Iacobelli, S., Sismondi, P., Giai, M., D'Egidio, M., Tinari, N., Amatetti, C., Di Stefano, P., and Natoli, C. (1994) Prognostic value of a novel circulating serum 90K antigen in breast cancer. Br. J. Cancer 69, 172-176
19. Ozaki, Y., Kontani, K., Hanaoka, J., Chano, T., Teramoto, K., Tezuka, N., Sawai, S., Fujino, S., Yoshiki, T., Okabe, H., and Ohkubo, I. (2002) Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma. Cancer 95, 1954-1962
20. Sardana, G., Marshall, J., and Diamandis, E. P. (2007) Discovery of candidate tumor markers for prostate cancer via proteomic analysis of cell culture-conditioned medium. Clin. Chem. 53, 429-437
21. Xue, H., Lu, B., and Lai, M. (2008) The cancer secretome: a reservoir of biomarkers. J. Transl. Med. 6, 52
22. Ulmer, T. A., Keeler, V., Loh, L., Chibbar, R., Torlakovic, E., André, S., Gabius, H. J., and Laferté, S. (2006) Tumor-associated antigen 90K/Mac-2-binding protein: possible role in colon cancer. J. Cell. Biochem. 98, 1351-1366
23. Scambia, G., Panici, P. B., Baiocchi, G., Perrone, L., Iacobelli, S., and Mancuso, S. (1988) Measurement of a monoclonal-antibody-defined antigen (90K) in the sera of patients with ovarian cancer. Anticancer Res. 8, 761-764
24. Cesinaro, A. M., Natoli, C., Grassadonia, A., Tinari, N., Iacobelli, S., and Trentini, G. P. (2002) Expression of the 90K tumor-associated protein in benign and malignant melanocytic lesions. J. Invest. Dermatol. 119, 187-190
25. Carlin, C. R., and Knowles, B. B. (1983) Identification of a 90 000-Dalton cell surface glycoprotein with elevated expression in human hepatoma cells. Exp. Cell Res. 147, 359-367
26. Iacovazzi, P. A., Trisolini, A., Barletta, D., Elba, S., Manghisi, O. G., and Correale, M. (2001) Serum 90K/MAC-2BP glycoprotein in patients with liver cirrhosis and hepatocellular carcinoma: a comparison with alphafetoprotein. Clin. Chem. Lab. Med. 39, 961-965
27. Kashyap, M. K., Harsha, H. C., Renuse, S., Pawar, H., Sahasrabuddhe, N. A., Kim, M. S., Marimuthu, A., Keerthikumar, S., Muthusamy, B., Kandasamy, K., Subbannayya, Y., Prasad, T. S., Mahmood, R., Chaerkady, R., Meltzer, S. J., Kumar, R. V., Rustgi, A. K., and Pandey, A. (2010) SILACbased quantitative proteomic approach to identify potential biomarkers from the esophageal squamous cell carcinoma secretome. Cancer Biol. Ther. 10, 796-810
28. Park, Y. P., Choi, S. C., Kim, J. H., Song, E. Y., Kim, J. W., Yoon, D. Y., Yeom, Y. I., Lim, J. S., Kim, J. W., Paik, S. G., and Lee, H. G. (2007) Up-regulation of Mac-2 binding protein by hTERT in gastric cancer. Int. J. Cancer 120, 813-820
29. Koopmann, J., Thuluvath, P. J., Zahurak, M. L., Kristiansen, T. Z., Pandey, A., Schulick, R., Argani, P., Hidalgo, M., Iacobelli, S., Goggins, M., and Maitra, A. (2004) Mac-2-binding protein is a diagnostic marker for biliary tract carcinoma. Cancer 101, 1609-1615
30. Srirajaskanthan, R., Caplin, M. E., Waugh, M. G., Watkins, J., Meyer, T., Hsuan, J. J., and Beaumont, N. J. (2010) Identification of Mac-2-binding protein as a putative marker of neuroendocrine tumors from the analysis of cell line secretomes. Mol. Cell Proteomics 9, 656-666
31. Grassadonia, A., Tinari, N., Iurisci, I., Piccolo, E., Cumashi, A., Innominato, P., D'Egidio, M., Natoli, C., Piantelli, M., and Iacobelli, S. (2004) 90K (Mac-2 BP) and galectins in tumor progression and metastasis. Glycoconj. J. 19, 551-556
32. Cladman, W. M., Watt, M. A., Dini, J. P., and Mellors, A. (1996) The Pasteurella haemolytica O-sialoglycoprotein endopeptidase is inhibited by zinc ions and does not cleave fetuin. Biochem. Biophys. Res. Commun. 220, 141-146
33. Sabit, I., Hashimoto, N., Matsumoto, Y., Yamaji, T., Furukawa, K., and Furukawa, K. (2013) Binding of a sialic acid-recognizing lectin Siglec-9 modulates adhesion dynamics of cancer cells via calpain-mediated protein degradation. J. Biol. Chem. 288, 35417-35427
34. Tanida, S., Akita, K., Ishida, A., Mori, Y., Toda, M., Inoue, M., Ohta, M., Yashiro, M., Sawada, T., Hirakawa, K., and Nakada, H. (2013) Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth. J. Biol. Chem. 288, 31842-31852
35. Cheong, K. A., Chang, Y. S., Roh, J. Y., Kim, B. J., Kim, M. N., Park, Y. M., Park, H. J., Kim, N. D., Lee, C. H., and Lee, A. Y. (2011) A novel function of Siglec-9 A391C polymorphism on T cell receptor signaling. Int. Arch. Allergy Immunol. 154, 111-118
36. Iacobelli, S., Bucci, I., D'Egidio, M., Giuliani, C., Natoli, C., Tinari, N., Rubistein, M., and Schlessinger, J. (1993) Purification and characterization of a 90 kDa protein released from human tumors and tumor cell lines. FEBS Lett. 319, 59-65
37. Inohara, H., Akahani, S., Koths, K., and Raz, A. (1996) Interactions between galectin-3 and Mac-2-binding protein mediate cell-cell adhesion. Cancer Res. 56, 4530-4534
38. Koths, K., Taylor, E., Halenbeck, R., Casipit, C., and Wang, A. (1993) Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. J. Biol. Chem. 268, 14245-14249
39. Hudak, J. E., Canham, S. M., and Bertozzi, C. R. (2014) Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion. Nat. Chem. Biol. 10, 69-75
40. Padler-Karavani, V., Song, X., Yu, H., Hurtado-Ziola, N., Huang, S., Muthana, S., Chokhawala, H. A., Cheng, J., Verhagen, A., Langereis, M. A., Kleene, R., Schachner, M., de Groot, R. J., Lasanajak, Y., Matsuda, H., Schwab, R., Chen, X., Smith, D. F., Cummings, R. D., and Varki, A. (2012) Cross-comparison of protein recognition of sialic acid diversity on two novel sialoglycan microarrays. J. Biol. Chem. 287, 22593-22608
41. Ohta, M., Ishida, A., Toda, M., Akita, K., Inoue, M., Yamashita, K., Watanabe, M., Murata, T., Usui, T., and Nakada, H. (2010) Immunomodulation of monocyte-derived dendritic cells through ligation of tumor-produced mucins to Siglec-9. Biochem. Biophys. Res. Commun. 402, 663-669
42. Mitic, N., Milutinovic, B., and Jankovic, M. (2012) Assessment of sialic acid diversity in cancer- and non-cancer related CA125 antigen using sialic acid-binding Ig-like lectins (Siglecs). Dis. Markers 32, 187-194
43. Tyler, C., Kapur, A., Felder, M., Belisle, J. A., Trautman, C., Gubbels, J. A., Connor, J. P., and Patankar, M. S. (2012) The mucin MUC16 (CA125) binds to NK cells and monocytes from peripheral blood of women with healthy pregnancy and preeclampsia. Am. J. Reprod. Immunol. 68, 28-37
44. Belisle, J. A., Horibata, S., Jennifer, G. A., Petrie, S., Kapur, A., André, S., Gabius, H. J., Rancourt, C., Connor, J., Paulson, J. C., and Patankar, M. S. (2010) Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes. Mol. Cancer 9, 118
45. Aalto, K., Autio, A., Kiss, E. A., Elima, K., Nymalm, Y., Veres, T. Z., Mart-tila- Ichihara, F., Elovaara, H., Saanijoki, T., Crocker, P. R., Maksimow, M., Bligt, E., Salminen, T. A., Salmi, M., Roivainen, A., and Jalkanen, S. (2011) Siglec-9 is a novel leukocyte ligand for vascular adhesion protein-1 and can be used in PET imaging of inflammation and cancer. Blood 118, 3725-3733
46. Yurugi, H., Tanida, S., Akita, K., Ishida, A., Toda, M., and Nakada, H. (2013) Prohibitins function as endogenous ligands for Siglec-9 and negatively regulate TCR signaling upon ligation. Biochem. Biophys. Res. Commun. 434, 376-381
47. Sackstein, R. (2012) Engineering cellular trafficking via glycosyltrans-ferase-programmed stereosubstitution. Ann. N.Y. Acad. Sci. 1253, 193-200
48. Pegon, J. N., Kurdi, M., Casari, C., Odouard, S., Denis, C. V., Christophe, O. D., and Lenting, P. J. (2012) Factor VIII and von Willebrand factor are ligands for the carbohydrate-receptor Siglec-5. Haematologica 97, 1855-1863
49. 2+ in neutrophil granulocytes via sialic acid binding immunoglobulinlike lectins (siglecs). FASEB J. 21, 4059-4069
50. Chen, G. Y., Tang, J., Zheng, P., and Liu, Y. (2009) CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science 323, 1722-1725
51. Bandala-Sanchez, E., Zhang, Y., Reinwald, S., Dromey, J. A., Lee, B. H., Qian, J., Böhmer, R. M., and Harrison, L. C. (2013) T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10. Nat. Immunol. 14, 741-748
52. Polgar, J., Matuskova, J., and Wagner, D. D. (2005) The P-selectin, tissue factor, coagulation triad. J. Thromb. Haemost. 3, 1590-1596
53. Wang, X., Chow, R., Deng, L., Anderson, D., Weidner, N., Godwin, A. K., Bewtra, C., Zlotnik, A., Bui, J., Varki, A., and Varki, N. (2011) Expression of Siglec-11 by human and chimpanzee ovarian stromal cells, with uniquely human ligands: implications for human ovarian physiology and pathology. Glycobiology 21, 1038-1048
54. Ikehara, Y., Ikehara, S. K., and Paulson, J. C. (2004) Negative regulation of T cell receptor signaling by Siglec-7 (p70/AIRM) and Siglec-9. J. Biol. Chem. 279, 43117-43125
55. Iacobelli, S., Arnò, E., D'Orazio, A., and Coletti, G. (1986) Detection of antigens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res. 46, 3005-3010
56. Linsley, P. S., Horn, D., Marquardt, H., Brown, J. P., Hellström, I., Hellström, K. E., Ochs, V., and Tolentino, E. (1986) Identification of a novel serum protein secreted by lung carcinoma cells. Biochemistry 25, 2978-2986
57. Ullrich, A., Sures, I., D'Egidio, M., Jallal, B., Powell, T. J., Herbst, R., Dreps, A., Azam, M., Rubinstein, M., and Natoli, C. (1994) The secreted tumor-associated antigen 90K is a potent immune stimulator. J. Biol. Chem. 269, 18401-18407
58. Altindag, Z. Z., Marth, C., Werner-Felmayer, G., Natoli, C., Zeimet, A. G., Wachter, H., Iacobelli, S., and Fuchs, D. (1996) Tumor-associated antigen 90K activates myelomonocytic cell line THP-1. Cancer Lett. 107, 143-148
59. Stampolidis, P., Ullrich, A., and Iacobelli, S. (2013) LGALS3BP, lectin galactoside-binding soluble 3 binding protein, promotes oncogenic cellular events impeded by antibody intervention. Oncogene 10.1038/onc.2013.548
60. Piccolo, E., Tinari, N., Semeraro, D., Traini, S., Fichera, I., Cumashi, A., La Sorda, R., Spinella, F., Bagnato, A., Lattanzio, R., D'Egidio, M., Di Risio, A., Stampolidis, P., Piantelli, M., Natoli, C., Ullrich, A., and Iacobelli, S. (2013) LGALS3BP, lectin galactoside-binding soluble 3 binding protein, induces vascular endothelial growth factor in human breast cancer cells and promotes angiogenesis. J. Mol. Med. 91, 83-94
61. Traini, S., Piccolo, E., Tinari, N., Rossi, C., La Sorda, R., Spinella, F., Bagnato, A., Lattanzio, R., D'Egidio, M., Di Risio, A., Tomao, F., Grassadonia, A., Piantelli, M., Natoli, C., and Iacobelli, S. (2014) Inhibition of tumor growth and angiogenesis by SP-2, an anti-LGALS3BP antibody. Mol. Cancer Ther. 13, 916-925
62. Silverman, A. M., Nakata, R., Shimada, H., Sposto, R., and DeClerck, Y. A. (2012) A galectin-3-dependent pathway upregulates interleukin-6 in the microenvironment of human neuroblastoma. Cancer Res. 72, 2228-2238
63. Friedman, J., Trahey, M., and Weissman, I. (1993) Cloning and characterization of cyclophilin C-associated protein: a candidate natural cellular ligand for cyclophilin C. Proc. Natl. Acad. Sci. U.S.A. 90, 6815-6819
64. Trahey, M., and Weissman, I. L. (1999) Cyclophilin C-associated protein: a normal secreted glycoprotein that down-modulates endotoxin and proinflammatory responses in vivo. Proc. Natl. Acad. Sci. U.S.A. 96, 3006-3011
65. McMillan, S. J., Sharma, R. S., McKenzie, E. J., Richards, H. E., Zhang, J., Prescott, A., and Crocker, P. R. (2013) Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b β2-in-tegrin-dependent signaling. Blood 121, 2084-2094
66. Läubli, H., Spanaus, K. S., and Borsig, L. (2009) Selectin-mediated activation of endothelial cells induces expression of CCL5 and promotes metastasis through recruitment of monocytes. Blood 114, 4583-4591